Forecast, save and improve lives
Telefon LinkedIn
INVESTOR RELATIONS


Kontaktieren Sie uns jederzeit gerne: Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein.


Vorhersage Plattform um klinische Entscheidungen zu Unterstützen

 

Warum in NeoPrediX investieren?


  • Software-as-a-Service
  • Digital Health
  • bahnbrechende Vorhersagesoftware
  • weltweites Marktpotenzial
  • Engagiertes Team von Wissenschafts- und Marktexperten
INVESTOREN MEDIEN ZENTRUM:


Intro NeoPrediX B.1
About us
Our employees about NeoPrediX
NeoPrediX @LSI USA `22
 



Pressemeldungen


Multi-Center Observational Study

Clinical Decision Support Company NeoPrediX AG Completes Prospective Multi-Center Observational Study

Basel, Switzerland, Regensburg, Germany, and Ft. Lauderdale, FL, USA, May 25, 2022 – NeoPrediX AG, a privately held maternal and neonatal clinical decision support company focused on the development and commercialization of intelligent algorithms to predict dynamic progression of disease parameters during the first 1,000 days of life, announced at a poster presentation during the recent 48th Annual Meeting of the German Society for Neonatology and Pediatric Intensive Medicine held in Aachen, Germany, that a prospective multi-center observational study was formally completed.

weiterlesen

NeoPrediX PRESENT AT BIOTECH SHOWCASE™ 2022

Breakthrough Prediction Software Platform of NeoPrediX shown at BIOTECH SHOWCASE

Regensburg, Germany. 22nd of December 2021 – NeoPrediX today announced that it will be presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation.

weiterlesen

Start-up company opens first US office

NeoPrediX starts marketing its prediction software platform in USA

November 15, 2021 - With the establishment of NeoPrediX USA in Fort Lauderdale (Florida) the German/Swiss NeoPredix AG starts its US business and pushes its internationalization strategy. The start-up company develops prediction software for hospitals and neonatal units based on scientific and clinical data as well as science-based algorithms.

weiterlesen
Wer ist NeoPrediX?


NeoPrediX AG is a Swiss company located in Basel with subsidiaries in Regensburg, Germany and Ft. Lauderdale, Florida, USA.

Kontakt


Sie möchten uns näher kennenlernen?
Schreiben Sie uns gerne Ihre Fragen oder Wünsche!
Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein.

NeoPrediX AG (Switzerland)
Aeschengraben 20, 4051 Basel, Switzerland
Executive Team: Jörg Schmidt, Prof. Dr. Marc Pfister , Prof. Dr. Sven Wellmann
Registered office: Basel
Commercial register number CH-270.3.016.001-3
Chairman of the board: Dr. Gerhard Ries

NeoPrediX USA, Inc. (US)
110 E Broward Blvd #1700
Fort Lauderdale, FL 33301, United States
Phone: +1 (954)-315-3884

NeoPrediX AG (Germany)
Franz-Mayer-Straße 1, 93053 Regensburg
Excecutive Board: Thorsten Waloschek (chairman), Jörg Schmidt
Registered Office: Regensburg
Commercial register number: HRB 18679
Supervisory Board: Dr. Volker Pfahlert (chairman), Arne Kirchner, Prof. Dr. Marc Pfister, Dr. Gerhard Ries, Prof. Dr. Sven Wellmann